Estrella Immunopharma ESLA
NASDAQ ESLA
$0.69 +0.14 (+26.35%)
As of: Oct 22, 2026 · 1:16 PM EDT

Estrella Immunopharma (ESLA) Receivables (2023)

Updated

Estrella Immunopharma's Receivables was $273,066 in Q1 2024, unchanged from the prior quarter.

Analysis

Estrella Immunopharma (ESLA) Receivables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,166.97 Bn 1,135.56 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 644.38 Bn 564.24 Bn 17.30 Bn 18.99 Bn
3 AbbVie 501.54 Bn 474.65 Bn 12.70 Bn 13.82 Bn
4 Merck 359.36 Bn 313.74 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 302.13 Bn 266.12 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 267.59 Bn 241.28 Bn 12.86 Bn 15.68 Bn
7 Amgen 241.49 Bn 196.89 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn 5.06 Bn
9 Pfizer 171.77 Bn 118.41 Bn 10.94 Bn 12.49 Bn
10 Estrella Immunopharma 29.94 Mn 24.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 273,066.00
Jun 30, 2023 273,066.00
API Access

Estrella Immunopharma Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ESLA&period=max&api_key=YOUR_API_KEY